CLEC10A and neoplasm: HERV-K (HERV-K env) was identified as a novel tumor antigen and prognostic indicator. Higher HERV-K (HML-2) env protein levels are associated with better disease-specific survival rates, suggesting potential as a prognostic marker [129].